Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer

References

• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Jeon J, Du M, Schoen RE, et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154:2152–2164.e19. doi:10.1053/j.gastro.2018.02.021
   PubMed Web of Science ®Google Scholar
• Vitiello GAF, Losi Guembarovski R, Amarante MK, Ceribelli JR. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups. Cytokine. 2018;103:121–126. doi:10.1016/j.cyto.2017.09.019
   PubMed Web of Science ®Google Scholar
• Stephens KE, Levine JD, Aouizerat BE, Paul SM, Abrams G. Associations between genetic and epigenetic variations in cytokine genes and mild persistent breast pain in women following breast cancer surgery. Cytokine. 2017;99:203–213. doi:10.1016/j.cyto.2017.07.006
   PubMed Web of Science ®Google Scholar
• Zidi S, Gazouani E, Stayoussef M, Mezlini A, Ahmed SK, Yacoubi-Loueslati B. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians. Cytokine. 2015;76(2):343–347. doi:10.1016/j.cyto.2015.05.028
   PubMed Web of Science ®Google Scholar
• Dwivedi S, Goel A, Khattri S, Mandhani A, Sharma P. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: an explorative study of prostate cancer patients in North Indian populations. Cytokine. 2015;74(1):117–122. doi:10.1016/j.cyto.2015.04.001
   PubMed Web of Science ®Google Scholar
• Zhou L, Xie J, Gu EL, Huang Y, Qu Y, Xu AP. Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies. Cytokine. 2015;72(2):154–159. doi:10.1016/j.cyto.2014.12.021
   Web of Science ®Google Scholar
• Kiyohara C, Horiuchi T. Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan. Cytokine. 2014;65(1):88–94. doi:10.1016/j.cyto.2013.09.015
   PubMed Web of Science ®Google Scholar
• Qiu LX, He J, Wang MY, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56(3):695–698. doi:10.1016/j.cyto.2011.09.001
   Web of Science ®Google Scholar
• Kshattry S, Saha A, Gries P, Tiziani S, Stone E. Enzyme-mediated depletion of l-cyst (e) ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth. NPJ Precis Oncol. 2019;3:16. doi:10.1038/s41698-019-0088-z
   Web of Science ®Google Scholar
• Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov. 2006;5(5):399–410. doi:10.1038/nrd2029
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800. doi:10.1038/nri1200
   PubMed Web of Science ®Google Scholar
• Bin Lim S, Chua MLK, Yeong JPS, Tan SJ. Pan-cancer analysis connects tumor matrisome to immune response. NPJ Precis Oncol. 2019;3:15. doi:10.1038/s41698-019-0087-0
   PubMed Web of Science ®Google Scholar
• Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218–228. doi:10.1016/S1470-2045(12)70582-X
   PubMed Web of Science ®Google Scholar
• Han Z, Qu J, Zhao J, Zou X. Genetic variant rs755622 regulates expression of the multiple sclerosis severity modifier d-dopachrome tautomerase in a sex-specific way. Biomed Res Int. 2018;2018:8285653. doi:10.1155/2018/8285653
   Web of Science ®Google Scholar
• Sharaf-Eldein M, Elghannam D, Abdel-Malak C. MIF-173G/C (rs755622) polymorphism as a risk factor for acute lymphoblastic leukemia development in children. J Gene Med. 2018;20(9):e3044. doi:10.1002/jgm.3044
   PubMed Web of Science ®Google Scholar
• Areeshi MY, Mandal RK, Dar SA, et al. MIF −173 G > C (rs755622) gene polymorphism modulates tuberculosis risk: evidence from a meta-analysis and trial sequential analysis. Sci Rep. 2017;7(1):17003. doi:10.1038/s41598-017-17308-y
   Web of Science ®Google Scholar
• Ma G, Yuan Q, Wang Q, et al. Association between mif-as rs755622 and nephrolithiasis risk in a chinese population. Med Sci Monit. 2016;22:563–568. doi:10.12659/MSM.895818
   Web of Science ®Google Scholar
• Luo JY, Xu R, Li XM, et al. Polymorphism rs755622 is associated with coronary artery disease and severity of coronary lesions in a chinese kazakh population: a case-control study. Medicine. 2016;95(4):e2617. doi:10.1097/MD.0000000000002617
   Web of Science ®Google Scholar
• Castaneda-Moreno VA, De la Cruz-mosso U, Torres-Carrillo N, Macias-Islas MA. MIF functional polymorphisms (−794 CATT5–8 and −173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. J Neuroimmunol. 2018;320:117–124. doi:10.1016/j.jneuroim.2018.04.006
   Web of Science ®Google Scholar
• Qian L, Wang XY, Thapa S, et al. Macrophage migration inhibitory factor promoter polymorphisms (−794 CATT5–8): relationship with soluble MIF levels in coronary atherosclerotic disease subjects. BMC Cardiovasc Disord. 2017;17(1):144. doi:10.1186/s12872-017-0570-x
   Web of Science ®Google Scholar
• Martinez-Guzman MA, Alvarado-Navarro A, Pereira-Suarez AL, Munoz-Valle JF, Fafutis-Morris M. Association between STR −794 CATT 5–8 and SNP −173 G/C polymorphisms in the MIF gene and Lepromatous Leprosy in Mestizo patients of western Mexico. Hum Immunol. 2016;77(10):985–989. doi:10.1016/j.humimm.2016.07.006
   Web of Science ®Google Scholar
• Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-mosso U, et al. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (−794 CATT5–8 and −173 G>C): association with MIF and TNFalpha in psoriatic arthritis. Int J Clin Exp Med. 2014;7(9):2605–2614.
   PubMed Web of Science ®Google Scholar
• De la Cruz-mosso U, Bucala R, Palafox-Sanchez CA, et al. Macrophage migration inhibitory factor: association of −794 CATT5–8 and −173 G>C polymorphisms with TNF-alpha in systemic lupus erythematosus. Hum Immunol. 2014;75(5):433–439. doi:10.1007/s12032-014-0241-z
   Web of Science ®Google Scholar
• Tong X, Zheng B, Tong Q, et al. MIF −173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test. Int J Clin Exp Med. 2015;8(9):15949–15957.
   Web of Science ®Google Scholar
• Wang CD, Li TM, Ren ZJ. Contribution of macrophage migration inhibitory factor −173G/C gene polymorphism to the risk of cancer in chinese population. Asian Pac J Cancer Prev. 2015;16(11):4597–4601. doi:10.7314/APJCP.2015.16.11.4597
   Google Scholar
• Zhang X, Weng W, Xu W, et al. The association between the migration inhibitory factor −173G/C polymorphism and cancer risk: a meta-analysis. Onco Targets Ther. 2015;8:601–613. doi:10.2147/OTT.S72795
   Web of Science ®Google Scholar
• Crunkhorn S. Designing cytokine mimics can optimize cancer therapy potential. Nat Rev Drug Discov. 2019;18(3):173. doi:10.1038/d41573-019-00020-z
   Web of Science ®Google Scholar
• Zagozda M, Sarnecka AK, Staszczak Z. Correlation of TNF-alpha and TGF-beta polymorphisms with protein levels in pancreatic ductal adenocarcinoma and colorectal cancer. Contemp Oncol. 2019;23(4):214–219. doi:10.5114/wo.2019.91537
   Google Scholar
• Karakaxas D, Gazouli M, Coker A, Agalianos C, Papanikolaou IS, Patapis P. Genetic polymorphisms of inflammatory response gene TNF-alpha and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk. Med Oncol. 2014;31(10):241.
   Web of Science ®Google Scholar
• Cigrovski Berkovic M, Catela Ivkovic T, Marout J, Zjacic-Rotkvic V, Kapitanovic S. Interleukin 1beta gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors. DNA Cell Biol. 2012;31(4):531–536. doi:10.1089/dna.2011.1317
   Web of Science ®Google Scholar
• Loomans-Kropp HA, Umar A. Cancer prevention and screening: the next step in the era of precision medicine. NPJ Precis Oncol. 2019;3:3. doi:10.1038/s41698-018-0075-9
   PubMed Web of Science ®Google Scholar
• Katayama H, Tsou P, Kobayashi M, Capello M, Wang H, Esteva F. A plasma protein derived TGFbeta signature is a prognostic indicator in triple negative breast cancer. NPJ Precis Oncol. 2019;3:10.
   PubMed Web of Science ®Google Scholar
• Renner P. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis. 2005;41(Suppl 7):S513–519. doi:10.1086/432009
   PubMed Web of Science ®Google Scholar
• Xue N, Lin JH, Xing S, et al. Plasma macrophage migration inhibitory factor and ccl3 as potential biomarkers for distinguishing patients with nasopharyngeal carcinoma from high-risk individuals who have positive epstein-barr virus capsid antigen-specific IgA. Cancer Research Treatment. 2019;51(1):378–390. doi:10.4143/crt.2018.070
   Web of Science ®Google Scholar
• Li YS, Chen W, Liu S. Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke. Int J Neurosci. 2017;127(6):539–546. doi:10.1080/00207454.2016.1211648
   PubMed Web of Science ®Google Scholar
• Salem SA, Asaad MK. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata. Int J Dermatol. 2016;55(12):1357–1361. doi:10.1111/ijd.13344
   Web of Science ®Google Scholar
• Shang ZB, Wang J, Kuai SG, Zhang YY, Ou QF. Serum macrophage migration inhibitory factor as a biomarker of active pulmonary tuberculosis. Ann Lab Med. 2018;38(1):9–16. doi:10.3343/alm.2018.38.1.9
   Web of Science ®Google Scholar
• Ning J, Xu L, Shen CQ. Increased serum levels of macrophage migration inhibitory factor in autism spectrum disorders. Neurotoxicology. 2019;71:1–5. doi:10.1016/j.neuro.2018.11.015
   PubMed Web of Science ®Google Scholar
• Xiang X, Wang Y, Zhang H, et al. Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a beta1-integrin-FAK-YAP1/TAZ signaling pathway. NPJ Precis Oncol. 2018;2(1):2. doi:10.1038/s41698-017-0045-7
   Web of Science ®Google Scholar
• Witek MA, Aufforth RD, Wang H. et al. Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule. NPJ Precis Oncol;2017. 1. doi:10.1038/s41698-017-0028-8
   Web of Science ®Google Scholar